Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A Multicentre, Randomised, Double-Blind, Placebo Controlled, Phase II Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable Implants of Afamelanotide (CUV1647) for the Prophylactic Treatment of Pre-Cancerous Skin Lesions of the Head, Forearms and Hands in Immune Compromised, Organ Transplant Patients (Report)
For hair and skin, the evidence includes topical skin trials, wound studies, mouse hair-follicle data, and related copper-peptide hair follicle models rather than large, modern randomized trials for hair loss [2], [3], [6], [13]
Reconstitution, sourcing, and COA questions welcome
Protective effects of vitamins/antioxidants on occupational noise-induced hearing loss: A systematic review
US$ 23.64
US$ 25.81
US$ 29.72
US$ 23.52
US$ 27.08
US$ 28.93
US$ 29.27
